Researchers identify gap in European bronchiectasis treatment

A recent study published in the European Respiratory Journal reveals that nearly half of European individuals with bronchiectasis fail to regularly practice airway clearance management, despite its recommendation as a crucial aspect of treatment. Led by Dr. Arietta Spinou, the study, involving international experts, utilized data from the European Bronchiectasis Registry (EMBARC) and examined various airway clearance techniques and devices. Results showed that only 52% of participants reported using regular airway clearance management, despite 72% reporting daily sputum expectoration.

The study highlights a need for improved uptake and standardization of airway clearance management across Europe to reduce exacerbations and improve quality of life. Additionally, disparities in the use of airway clearance techniques were observed between countries, indicating a lack of evidence-based practice and emphasizing the need for further research in bronchiectasis treatments, including mucoactive drugs.

4 Likes

it’s imperative that healthcare systems prioritize access to comprehensive care and treatment options to better support patients and improve outcomes in the management of this chronic respiratory condition.

1 Like

It’s concerning to see that many individuals aren’t practicing airway clearance regularly, despite its benefits. Hopefully, this research will lead to better awareness and more effective treatments for everyone affected

1 Like

Wow, this study on bronchiectasis management is really eye-opening! It’s surprising to learn that almost half of the individuals in Europe aren’t regularly practicing airway clearance, especially when it’s recommended as such an important part of treatment. Do you think there are specific barriers or challenges that might be preventing people from following through with their airway clearance routines?

1 Like